Hostname: page-component-cd9895bd7-mkpzs Total loading time: 0 Render date: 2024-12-23T04:16:17.810Z Has data issue: false hasContentIssue false
  • English
  • Français

Apathy in Parkinson's Disease: More Than Just Executive Dysfunction

Published online by Cambridge University Press:  21 February 2013

Saül Martínez-Horta ,
Javier Pagonabarraga ,
Ramón Fernández de Bobadilla ,
Carmen García-Sanchez  and
Jaime Kulisevsky
Saül Martínez-Horta
Affiliation:
Neurology Department, Movement Disorders Unit, Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona. Barcelona, Spain Sant Pau Institute of Biomedical Research (IIB-Sant Pau), Barcelona, Spain
Javier Pagonabarraga
Affiliation:
Neurology Department, Movement Disorders Unit, Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona. Barcelona, Spain Sant Pau Institute of Biomedical Research (IIB-Sant Pau), Barcelona, Spain
Ramón Fernández de Bobadilla
Affiliation:
Neurology Department, Movement Disorders Unit, Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona. Barcelona, Spain Sant Pau Institute of Biomedical Research (IIB-Sant Pau), Barcelona, Spain
Carmen García-Sanchez
Affiliation:
Neurology Department, Movement Disorders Unit, Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona. Barcelona, Spain
Jaime Kulisevsky*
Affiliation:
Neurology Department, Movement Disorders Unit, Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona. Barcelona, Spain Sant Pau Institute of Biomedical Research (IIB-Sant Pau), Barcelona, Spain Centro Investigación Biomedica en Red-Enfermedades Neurodegenerativas (CIBERNED), Spain
*
Correspondence and reprint requests to: Jaime Kulisevsky, Movement Disorders Unit, Neurology Department, Sant Pau Hospital, Sant Antoni M. Claret 167,08025 Barcelona, Spain. E-mail: [email protected]
Get access Rights & Permissions [Opens in a new window]

Abstract

Apathy is a frequent syndrome in Parkinson's disease (PD) usually associated with depression, cognitive impairment (CI), and dementia. Whereas executive dysfunction seems to play a major causative role in the development of apathy in PD, recent findings pointed for the possible participation of other underlying mechanisms in the development of clinically meaningful symptoms of apathy. By means of neuropsychological testing focused over global cognitive functioning, set-shifting, decision making, and cognitive effort, we compared to a control group, a carefully selected sample of PD patients presenting apathy as the only neuropsychiatric symptom and without clinically relevant signs of cognitive impairment. In addition to the previously reported executive dysfunction, apathetic patients also exhibited significant difficulties in tasks assessing for cortical functioning, such as naming and clock drawing. Moreover, apathetic patients performed significantly better on a decision-making task, although any of these differences appeared linked to a lack of effort when performing the tasks. On the basis of our findings, we discuss the possible implication of added mechanisms rather than just executive dysfunction in the development of apathy in PD. (JINS, 2013, 19, 1–12.)

Keywords

ApathyParkinson's diseaseCognitionExecutive dysfunctionRewardCognitive impairment
Type
Research Articles
Information
Journal of the International Neuropsychological Society , Volume 19 , Issue 5 , May 2013 , pp. 571 - 582
Copyright
Copyright © The International Neuropsychological Society 2013

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Aarsland, D., Bronnick, K., Alves, G., Tysnes, O.B., Pedersen, K.F., Ehrt, U., Larsen, J.P. (2009). The spectrum of neuropsychiatric symptoms in patients with early untreated Parkinson's disease. Journal of Neurology, Neurosurgery and Psychiatry, 80(8), 928–930. doi:80/8/928 [pii] 10.1136/jnnp.2008.166959CrossRefGoogle ScholarPubMed
Aarsland, D., Muniz, G., Matthews, F. (2011). Nonlinear decline of mini-mental state examination in Parkinson's disease. Movement Disorders, 26, 334–337. doi:10.1002/mds.23416CrossRefGoogle ScholarPubMed
Aarts, E., Helmich, R.C., Janssen, M.J., Oyen, W.J., Bloem, B.R., Cools, R. (2012). Aberrant reward processing in Parkinson's disease is associated with dopamine cell loss. [Research Support, Non-U.S. Gov't]. Neuroimage, 59(4), 3339–3346. doi:10.1016/j.neuroimage.2011.11.073CrossRefGoogle ScholarPubMed
Anderson, E., Nutt, J. (2011). The long-duration response to levodopa: Phenomenology, potential mechanisms and clinical implications. [Review]. Parkinsonism and Related Disorders, 17(8), 587–592. doi:10.1016/j.parkreldis.2011.03.014CrossRefGoogle ScholarPubMed
Ashendorf, L., Constantinou, M., McCaffrey, R.J. (2004). The effect of depression and anxiety on the TOMM in community-dwelling older adults. [Evaluation Studies]. Archives of Clinical Neuropsychology, 19(1), 125–130.CrossRefGoogle ScholarPubMed
Bauer, L., O'Bryant, S.E., Lynch, J.K., McCaffrey, R.J., Fisher, J.M. (2007). Examining the Test Of Memory Malingering Trial 1 and Word Memory Test Immediate recognition as screening tools for insufficient effort. [Validation Studies]. Assessment, 14(3), 215–222. doi:10.1177/1073191106297617CrossRefGoogle ScholarPubMed
Bechara, A., Damasio, A.R., Damasio, H., Anderson, S.W. (1994). Insensitivity to future consequences following damage to human prefrontal cortex. [Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.]. Cognition, 50(1–3), 7–15.CrossRefGoogle ScholarPubMed
Bechara, A., Tranel, D., Damasio, H. (2000). Characterization of the decision-making deficit of patients with ventromedial prefrontal cortex lesions. Brain, 123(Pt 11), 2189–2202.CrossRefGoogle ScholarPubMed
Braak, H., Bohl, J.R., Muller, C.M., Rub, U., de Vos, R.A., Del Tredici, K. (2006). Stanley Fahn Lecture 2005: The staging procedure for the inclusion body pathology associated with sporadic Parkinson's disease reconsidered. [Research Support, Non-U.S. Gov't Review]. Movement Disorders, 21(12), 2042–2051. doi:10.1002/mds.21065CrossRefGoogle Scholar
Braak, H., Muller, C.M., Rub, U., Ackermann, H., Bratzke, H., de Vos, R.A., Del Tredici, K. (2006). Pathology associated with sporadic Parkinson's disease-where does it end? Journal of Neural Transmission. Supplementum, 70, 89–97.Google Scholar
Brand, M., Kalbe, E., Labudda, K., Fujiwara, E., Kessler, J., Markowitsch, H.J. (2005). Decision-making impairments in patients with pathological gambling. Psychiatry Research, 133(1), 91–99. doi:10.1016/j.psychres.2004.10.003CrossRefGoogle ScholarPubMed
Burke, C.J., Tobler, P.N., Schultz, W., Baddeley, M. (2010). Striatal BOLD response reflects the impact of herd information on financial decisions. Frontiers in Human Neuroscience, 4, 48. doi:10.3389/fnhum.2010.00048Google ScholarPubMed
Cools, R., Altamirano, L., D'Esposito, M. (2006). Reversal learning in Parkinson's disease depends on medication status and outcome valence. [Comparative Study Research Support, N.I.H., Extramural Research Support, U.S. Gov't, Non-P.H.S.]. Neuropsychologia, 44(10), 1663–1673. doi:10.1016/j.neuropsychologia.2006.03.030CrossRefGoogle ScholarPubMed
Cools, R., Stefanova, E., Barker, R.A., Robbins, T.W., Owen, A.M. (2002). Dopaminergic modulation of high-level cognition in Parkinson's disease: The role of the prefrontal cortex revealed by PET. Brain, 125(Pt 3), 584–594.CrossRefGoogle ScholarPubMed
Cummings, J.L. (1993). Frontal-subcortical circuits and human behavior. [Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S. Research Support, U.S. Gov't, P.H.S. Review]. Archives of Neurology, 50(8), 873–880.CrossRefGoogle ScholarPubMed
Cummings, J.L. (1998). Frontal-subcortical circuits and human behavior. Journal of Psychosomatic Research, 44(6), 627–628.Google ScholarPubMed
da Rocha, F.F., Alvarenga, N.B., Malloy-Diniz, L., Correa, H. (2011). Decision-making impairment in obsessive-compulsive disorder as measured by the Iowa Gambling Task. Arquivos de Neuro-Psiquiatria, 69(4), 642–647.CrossRefGoogle ScholarPubMed
Daniel, S.E., Lees, A.J. (1993). Parkinson's Disease Society Brain Bank, London: Overview and research. Journal of Neural Transmission. Supplementum, 39, 165–172.Google Scholar
Dujardin, K., Sockeel, P., Delliaux, M., Destee, A., Defebvre, L. (2009). Apathy may herald cognitive decline and dementia in Parkinson's disease. Movement Disorders, 24(16), 2391–2397. doi:10.1002/mds.22843CrossRefGoogle ScholarPubMed
Dujardin, K., Sockeel, P., Devos, D., Delliaux, M., Krystkowiak, P., Destee, A., Defebvre, L. (2007). Characteristics of apathy in Parkinson's disease. Movement Disorders, 22(6), 778–784. doi:10.1002/mds.21316CrossRefGoogle ScholarPubMed
Emre, M., Aarsland, D., Brown, R., Burn, D.J., Duyckaerts, C., Mizuno, Y., Dubois, B. (2007). Clinical diagnostic criteria for dementia associated with Parkinson's disease. Movement Disorders, 22, 1689–1707.CrossRefGoogle ScholarPubMed
Euteneuer, F., Schaefer, F., Stuermer, R., Boucsein, W., Timmermann, L., Barbe, M.T., Kalbe, E. (2009). Dissociation of decision-making under ambiguity and decision-making under risk in patients with Parkinson's disease: A neuropsychological and psychophysiological study. [Controlled Clinical Trial Research Support, Non-U.S. Gov't]. Neuropsychologia, 47(13), 2882–2890. doi:10.1016/j.neuropsychologia.2009.06.014CrossRefGoogle ScholarPubMed
Folstein, M.F., Folstein, S.E., McHugh, P.R. (1975). “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research, 12(3), 189–198. doi:0022-3956(75)90026-6 [pii]CrossRefGoogle ScholarPubMed
Frank, M.J., Seeberger, L.C., O'Reilly, R.C. (2004). By carrot or by stick: Cognitive reinforcement learning in parkinsonism. Science, 306(5703), 1940–1943. doi:1102941 [pii] 10.1126/science.1102941CrossRefGoogle ScholarPubMed
Goetz, C.G., Tilley, B.C., Shaftman, S.R., Stebbins, G.T., Fahn, S., Martinez-Martin, P., LaPelle, N. (2008). Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): Scale presentation and clinimetric testing results. Movement Disorders, 23(15), 2129–2170. doi:10.1002/mds.22340CrossRefGoogle ScholarPubMed
Gotham, A.M., Brown, R.G., Marsden, C.D. (1986). Levodopa treatment may benefit or impair “frontal” function in Parkinson's disease. Lancet, 2(8513), 970–971. doi:S0140-6736(86)90617-3 [pii]CrossRefGoogle ScholarPubMed
Grace, J., Malloy, P.F. (2001). Frontal Systems Behavior Scale. Professional manual. Odessa, FL: Psychological Assessment Resources, Inc.Google Scholar
Heaton, R. (1981). Wisconsin Card Sorting Test. Manual. Odessa, FL: Psychological Assessment Ressources.Google Scholar
Hoehn, M.M., Yahr, M.D. (1967). Parkinsonism: Onset, progression and mortality. Neurology, 17(5), 427–442.CrossRefGoogle ScholarPubMed
Kirsch-Darrow, L., Fernandez, H.H., Marsiske, M., Okun, M.S., Bowers, D. (2006). Dissociating apathy and depression in Parkinson disease. Neurology, 67(1), 33–38. doi:67/1/33 [pii] 10.1212/01.wnl.0000230572.07791.22CrossRefGoogle ScholarPubMed
Kulisevsky, J., Avila, A., Barbanoj, M., Antonijoan, R., Berthier, M.L., Gironell, A. (1996). Acute effects of levodopa on neuropsychological performance in stable and fluctuating Parkinson's disease patients at different levodopa plasma levels. Brain, 119(Pt 6), 2121–2132.CrossRefGoogle ScholarPubMed
Lange, R.T., Iverson, G.L., Brooks, B.L., Rennison, V.L. (2010). Influence of poor effort on self-reported symptoms and neurocognitive test performance following mild traumatic brain injury. [Research Support, Non-U.S. Gov't]. Journal of Clinical and Experimental Neuropsychology, 32(9), 961–972. doi:10.1080/13803391003645657CrossRefGoogle ScholarPubMed
Lawrence, A.D., Goerendt, I.K., Brooks, D.J. (2011). Apathy blunts neural response to money in Parkinson's disease. [Research Support, Non-U.S. Gov't]. Social Neuroscience, 6(5–6), 653–662. doi:10.1080/17470919.2011.556821CrossRefGoogle ScholarPubMed
Lees, A.J., Smith, E. (1983). Cognitive deficits in the early stages of Parkinson's disease. Brain, 106(Pt 2), 257–270.CrossRefGoogle ScholarPubMed
Levy, R., Dubois, B. (2006). Apathy and the functional anatomy of the prefrontal cortex-basal ganglia circuits. Cerebral Cortex, 16(7), 916–928. doi:bhj043 [pii] 10.1093/cercor/bhj043CrossRefGoogle ScholarPubMed
Llebaria, G., Pagonabarraga, J., Kulisevsky, J., Garcia-Sanchez, C., Pascual-Sedano, B., Gironell, A., Martinez-Corral, M. (2008). Cut-off score of the Mattis Dementia Rating Scale for screening dementia in Parkinson's disease. Movement Disorders, 23(11), 1546–1550. doi:10.1002/mds.22173CrossRefGoogle ScholarPubMed
Litvan, I., Aarsland, D., Adler, C.H., Goldman, J.G., Kulisevsky, J., Mollenhauer, B., Weintraub, D. (2011). MDS Task Force on mild cognitive impairment in Parkinson's disease: critical review of PD-MCI. Movement Disorders, 26, 1814–1824. doi:10.1002/mds.23823CrossRefGoogle ScholarPubMed
Macdonald, A.A., Monchi, O., Seergobin, K.N., Ganjavi, H., Tamjeedi, R., Macdonald, P.A. (2012). Parkinson's disease duration determines effect of dopaminergic therapy on ventral striatum function. Movement Disorders. doi:10.1002/mds.25152 [Epub ahead of print].Google Scholar
Marin, R.S. (1991). Apathy: A neuropsychiatric syndrome. Journal of Neuropsychiatry and Clinical Neurosciences, 3(3), 243–254.Google Scholar
Martinez-Corral, M., Pagonabarraga, J., Llebaria, G., Pascual-Sedano, B., Garcia-Sanchez, C., Gironell, A., Kulisevsky, J. (2010). Facial emotion recognition impairment in patients with Parkinson's disease and isolated apathy. Parkinsonism and Related Disorders, 2010, 930627. doi:10.4061/2010/930627Google ScholarPubMed
Masliah, E., Rockenstein, E., Adame, A., Alford, M., Crews, L., Hashimoto, M., Schenk, D. (2005). Effects of alpha-synuclein immunization in a mouse model of Parkinson's disease. [Comparative Study Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.]. Neuron, 46(6), 857–868. doi:10.1016/j.neuron.2005.05.010CrossRefGoogle Scholar
Morris, J.C. (1993). The Clinical Dementia Rating (CDR): Current version and scoring rules. Neurology, 43(11), 2412–2414.CrossRefGoogle ScholarPubMed
Mumford, D.B. (1991). Hospital anxiety and depression scale. British Journal of Psychiatry, 159, 729.CrossRefGoogle ScholarPubMed
Muslimovic, D., Post, B., Speelman, J.D., Schmand, B. (2005). Cognitive profile of patients with newly diagnosed Parkinson disease. Neurology, 65(8), 1239–1245. doi:65/8/1239 [pii] 10.1212/01.wnl.0000180516.69442.95CrossRefGoogle ScholarPubMed
Nagahama, Y., Fukuyama, H., Yamauchi, H., Matsuzaki, S., Konishi, J., Shibasaki, H., Kimura, J. (1996). Cerebral activation during performance of a card sorting test. Brain, 119(Pt 5), 1667–1675.CrossRefGoogle ScholarPubMed
O'Bryant, S.E., Gavett, B.E., McCaffrey, R.J., O'Jile, J.R., Huerkamp, J.K., Smitherman, T.A., Humphreys, J.D. (2008). Clinical utility of Trial 1 of the Test of Memory Malingering (TOMM). [Validation Studies]. Applied Neuropsychology, 15(2), 113–116. doi:10.1080/09084280802083921CrossRefGoogle Scholar
Pagonabarraga, J., Kulisevsky, J., Llebaria, G., Garcia-Sanchez, C., Pascual-Sedano, B., Gironell, A. (2008). Parkinson's disease-cognitive rating scale: A new cognitive scale specific for Parkinson's disease. Movement Disorders, 23(7), 998–1005. doi:10.1002/mds.22007CrossRefGoogle Scholar
Pascual-Sedano, B., Kulisevsky, J., Barbanoj, M., Garcia-Sanchez, C., Campolongo, A., Gironell, A., Gich, I. (2008). Levodopa and executive performance in Parkinson's disease: A randomized study. Journal of the International Neuropsychological Society, 14(5), 832–841. doi:S1355617708081010 [pii] 10.1017/S1355617708081010CrossRefGoogle ScholarPubMed
Pedersen, K.F., Alves, G., Bronnick, K., Aarsland, D., Tysnes, O.B., Larsen, J.P. (2010). Apathy in drug-naive patients with incident Parkinson's disease: The Norwegian ParkWest study. [Multicenter Study Research Support, Non-U.S. Gov't]. Journal of Neurology, 257(2), 217–223. doi:10.1007/s00415-009-5297-xCrossRefGoogle ScholarPubMed
Pedersen, K.F., Larsen, J.P., Alves, G., Aarsland, D. (2009). Prevalence and clinical correlates of apathy in Parkinson's disease: A community-based study. Parkinsonism and Related Disorders, 15(4), 295–299. doi:S1353-8020(08)00231-9 [pii] 10.1016/j.parkreldis.2008.07.006CrossRefGoogle ScholarPubMed
Pluck, G.C., Brown, R.G. (2002). Apathy in Parkinson's disease. Journal of Neurology, Neurosurgery and Psychiatry, 73(6), 636–642.CrossRefGoogle ScholarPubMed
Poletti, M., De Rosa, A., Bonuccelli, U. (2012). Affective symptoms and cognitive functions in Parkinson's disease. [Review]. Journal of the Neurological Sciences, 317(1–2), 97–102. doi:10.1016/j.jns.2012.02.022CrossRefGoogle ScholarPubMed
Poletti, M., Frosini, D., Lucetti, C., Del Dotto, P., Ceravolo, R., Bonuccelli, U. (2010). Decision making in de novo Parkinson's disease. Movement Disorders, 25(10), 1432–1436. doi:10.1002/mds.23098CrossRefGoogle ScholarPubMed
Rees, L.M., Tombaugh, T.N., Boulay, L. (2001). Depression and the test of memory malingering. Archives of Clinical Neuropsychology, 16(5), 501–506.CrossRefGoogle ScholarPubMed
Reijnders, J.S., Scholtissen, B., Weber, W.E., Aalten, P., Verhey, F.R., Leentjens, A.F. (2010). Neuroanatomical correlates of apathy in Parkinson's disease: A magnetic resonance imaging study using voxel-based morphometry. Movement Disorders, 25(14), 2318–2325. doi:10.1002/mds.23268CrossRefGoogle ScholarPubMed
Rossi, M., Gerschcovich, E.R., de Achaval, D., Perez-Lloret, S., Cerquetti, D., Cammarota, A., Leiguarda, R. (2010). Decision-making in Parkinson's disease patients with and without pathological gambling. European Journal of Neurology, 17(1), 97–102. doi:10.1111/j.1468-1331.2009.02792.xCrossRefGoogle ScholarPubMed
Schultz, W., Dayan, P., Montague, P.R. (1997). A neural substrate of prediction and reward. [Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S. Review]. Science, 275(5306), 1593–1599.CrossRefGoogle ScholarPubMed
Slick, D.J., Tan, J.E., Strauss, E.H., Hultsch, D.F. (2004). Detecting malingering: A survey of experts’ practices. [Research Support, Non-U.S. Gov't]. Archives of Clinical Neuropsychology, 19(4), 465–473. doi:10.1016/j.acn.2003.04.001CrossRefGoogle ScholarPubMed
Starkstein, S.E. (2009). Neuropsychiatric disorders in early untreated Parkinson's disease. Journal of Neurology, Neurosurgery and Psychiatry, 80(8), 830. doi:80/8/830 [pii] 10.1136/jnnp.2008.171231CrossRefGoogle ScholarPubMed
Starkstein, S.E. (2010). Anticholinergic activity and cognitive decline in Parkinson's disease. [Comment Editorial]. Journal of Neurology, Neurosurgery and Psychiatry, 81(2), 129. doi:10.1136/jnnp.2009.194548CrossRefGoogle ScholarPubMed
Starkstein, S.E., Merello, M., Jorge, R., Brockman, S., Bruce, D., Power, B. (2009). The syndromal validity and nosological position of apathy in Parkinson's disease. Movement Disorders, 24(8), 1211–1216. doi:10.1002/mds.22577CrossRefGoogle ScholarPubMed
Teichner, G., Wagner, M.T. (2004). The Test of Memory Malingering (TOMM): Normative data from cognitively intact, cognitively impaired, and elderly patients with dementia. Archives of Clinical Neuropsychology, 19(3), 455–464. doi:10.1016/S0887-6177(03)00078-7CrossRefGoogle ScholarPubMed
Williams-Gray, C.H., Evans, J.R., Goris, A., Foltynie, T., Ban, M., Robbins, T.W., Barker, R.A. (2009). The distinct cognitive syndromes of Parkinson's disease: 5 year follow-up of the CamPaIGN cohort. Brain, 132(Pt11), 2958–2969. doi:awp245 [pii]10.1093/brain/awp245CrossRefGoogle ScholarPubMed
Yeterian, E.H., Pandya, D.N. (1991). Prefrontostriatal connections in relation to cortical architectonic organization in rhesus monkeys. Journal of Comparative Neurology, 312(1), 43–67. doi:10.1002/cne.903120105CrossRefGoogle ScholarPubMed
Zgaljardic, D.J., Borod, J.C., Foldi, N.S., Mattis, P. (2003). A review of the cognitive and behavioral sequelae of Parkinson's disease: Relationship to frontostriatal circuitry. Cognitive and Behavioral Neurology, 16(4), 193–210.CrossRefGoogle ScholarPubMed